{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:14:13Z","timestamp":1793506453167,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C2091165"],"award-info":[{"award-number":["2022R1A2C2091165"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00208890"],"award-info":[{"award-number":["RS-2023-00208890"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["23D0101L1"],"award-info":[{"award-number":["23D0101L1"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00332790"],"award-info":[{"award-number":["RS-2024-00332790"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cell.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:27:41Z","timestamp":1760372861000},"page":"7036-7048.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"188","author":[{"given":"Jin Woo","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Kyu","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Won","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Hyeon","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Taek","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Sang","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Young","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Youn","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inkyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.09.010_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's Disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41551-022-00987-y","article-title":"Challenges in the clinical advancement of cell therapies for Parkinson's disease","volume":"7","author":"Skidmore","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/d41586-025-00688-x","article-title":"Clinical trials test the safety of stem-cell therapy for Parkinson's disease","volume":"641","author":"Okano","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.09.010_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","article-title":"The future of stem cell therapies for Parkinson disease","volume":"21","author":"Parmar","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cell.2025.09.010_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mds.25343","article-title":"Cell therapy for Parkinson's disease: what next?","volume":"28","author":"Bjorklund","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson's disease","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2025.09.010_bib9","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2025.09.010_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes","volume":"12","author":"Roy","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/nprot.2008.188","article-title":"Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale","volume":"3","author":"Cho","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2025.09.010_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2025.09.010_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease","volume":"31","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2025.09.010_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.09.010_bib18","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","article-title":"Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale","volume":"21","author":"Mart\u00ednez-Mart\u00edn","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1227\/01.NEU.0000156473.57196.7E","article-title":"Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders","volume":"56","author":"Binder","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cell.2025.09.010_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1227\/01.NEU.0000339173.77240.34","article-title":"Risk factors for hemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design","volume":"64","author":"Ben-Haim","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cell.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mdc3.12553","article-title":"Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort","volume":"5","author":"Holden","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.cell.2025.09.010_bib23","first-page":"1521","article-title":"Dopamine transporter imaging with fluorine-18-FPCIT and PET","volume":"39","author":"Kazumata","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib24","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10579","article-title":"Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/mds.28110","article-title":"Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items","volume":"35","author":"Tosin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mdc3.13311","article-title":"Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models","volume":"8","author":"Luo","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.cell.2025.09.010_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/brain\/117.3.487","article-title":"Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon","volume":"117","author":"Peschanski","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.cell.2025.09.010_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease","volume":"293","author":"de la Fuente-Fern\u00e1ndez","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.09.010_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2967\/jnumed.124.268365","article-title":"Longitudinal Trajectory of Dopamine and Serotonin Transporters in Parkinson Disease","volume":"66","author":"Song","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib30","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.57.11.2089","article-title":"[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson\u2019s disease progression","volume":"57","author":"Marek","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2025.09.010_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13139-017-0481-x","article-title":"Longitudinal Decline of Striatal Subregional [18F]FP-CIT Uptake in Parkinson's Disease","volume":"51","author":"Sung","year":"2017","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.cell.2025.09.010_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in Early-Stage Parkinson's Disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in Early Parkinson's Disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JPD-212610","article-title":"The Placebo Response in Double-Blind Randomised Trials Evaluating Regenerative Therapies for Parkinson's Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Polgar","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cell.2025.09.010_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14161","article-title":"How calcineurin inhibitors affect cognition","volume":"240","author":"Thiankhaw","year":"2024","journal-title":"Acta Physiol. (Oxf.)"},{"key":"10.1016\/j.cell.2025.09.010_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109314","article-title":"Adverse cognitive effects of glucocorticoids: A systematic review of the literature","volume":"200","author":"Spannenburg","year":"2023","journal-title":"Steroids"},{"key":"10.1016\/j.cell.2025.09.010_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease","volume":"30","author":"Cools","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cell.2025.09.010_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1331.2011.03578.x","article-title":"Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy","volume":"19","author":"Miah","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cell.2025.09.010_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","article-title":"Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease","volume":"51","author":"Chung","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.09.010_bib41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.09.010_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01868-4","article-title":"Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease","volume":"11","author":"Goggi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.cell.2025.09.010_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JPD-2011-11070","article-title":"Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease","volume":"1","author":"Kikuchi","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cell.2025.09.010_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ana.410410308","article-title":"Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease","volume":"41","author":"Torstenson","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2025.09.010_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0404.2004.00299.x","article-title":"Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease","volume":"110","author":"Kumakura","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cell.2025.09.010_bib46","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/RLU.0000000000000383","article-title":"18F-DOPA, a clinically available PET tracer to study brain inflammation?","volume":"39","author":"Sala","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184625","article-title":"[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression","volume":"12","author":"Dadone-Montaudi\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cell.2025.09.010_bib48","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","article-title":"A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice","volume":"50","author":"Chahid","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.cell.2025.09.010_bib49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-021-00183-w","article-title":"Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease","volume":"7","author":"Greene","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.cell.2025.09.010_bib51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mds.22208","article-title":"Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis","volume":"24","author":"Olanow","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn863","article-title":"Dyskinesias following neural transplantation in Parkinson's disease","volume":"5","author":"Hagell","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2025.09.010_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2307\/2531693","article-title":"Design and analysis of phase I clinical trials","volume":"45","author":"Storer","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.cell.2025.09.010_bib54","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.09.010_bib55","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2025.09.010_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1399-0012.2003.00150.x","article-title":"Basiliximab in association with tacrolimus and steroids in caucasian cadaveric renal transplanted patients: significant decrease in early acute rejection rate and hospitalization time","volume":"18","author":"Leonardi","year":"2004","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cell.2025.09.010_bib57","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","article-title":"Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients","volume":"25","author":"Ahn","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cell.2025.09.010_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.14802\/jmd.16020","article-title":"The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease","volume":"9","author":"Kim","year":"2016","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.cell.2025.09.010_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2025.09.010_bib61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.111.095224","article-title":"Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy","volume":"53","author":"Oh","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib62","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00004647-200109000-00002","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum","volume":"21","author":"Mawlawi","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cell.2025.09.010_bib63","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2967\/jnumed.107.048330","article-title":"Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum","volume":"49","author":"Rousset","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cell.2025.09.010_bib65","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","article-title":"The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease","volume":"38","author":"Thomas","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.cell.2025.09.010_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nucmedbio.2004.10.001","article-title":"Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?","volume":"32","author":"Kish","year":"2005","journal-title":"Nucl. Med. Biol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425010414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425010414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:28:36Z","timestamp":1772688516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867425010414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0092867425010414"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.09.010","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}